Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Must-Sit in front of the Programs from Europe and the US - 2'We need everyone,' wounded reservist urges Knesset panel to advance haredi draft law
- 3Good ways to respond if your kid brings home less-than-ideal grades
- 4From Modesty to Administration: Self-improvement in Interactive abilities
- 5Keep It Cool: Uncovering Famous Fridge Brands for Each Home
- Instructions to Improve Your Mental Exploration with Cutting edge Measurements
- $30K Disability Scam Implodes After Surf Trip in Mexico
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- A Manual for Pick Dependable Vehicle Rental Administrations For 2024
- BHP liable for 2015 Brazil mine disaster: UK court
- Washington resident is infected with a different type of bird flu
- After harsh winter, Ukrainians find joy in releasing bats rescued from war
- Manual for Famous Beverages 2024
- 4K televisions for Extreme Film Watching Experience
